NuVasive CEO Gregory Lucier spoke on several key topics during the company's first quarter conference call, including biologics, outpatient spine and why NuVasive won't get into the robotics business, according to a Seeking Alpha transcript.
Spinal Tech
K2M CEO Eric Major discussed several key innovations and where the company is headed in the future during the first quarter conference call, according to a transcript in Seeking Alpha.
Paradigm Spine received FDA pre-market approval for its coflex Interlaminar Stabilization disposable instrument kit.
K2M releases its first quarter 2018 financial results, showing all areas of the business are booming.
Here are 11 key notes orthopedic and spine device companies from the past week.
Advertisement
Zimmer Biomet showcased a new technology platform for its craniomaxillofacial, bone healing and spine business units at the American Association of Neurological Surgeons Annual Meeting, April 28 to May 2, in New Orleans.
Zimmer Biomet partnered with nonprofit Faith In Practice to expand the access of implants to underserved communities.
Although, NuVasive reported first quarter 2018 revenues increased 4.6 percent year-over-year to $260.5 million, the company still reported a net loss.
Safe Orthopaedics reported its first quarter 2018 revenues and full-year 2017 results.
K2M hosted its annual Meeting of Minds, in Chicago, April 20 to 21. The symposium is K2M's largest comprehensive medical education program.